£520.00

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States

Price data last checked 84 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 7 days • 7 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 27 January 2026 29 January 2026 30 January 2026 01 February 2026

Price Distribution

Price distribution over 7 days • 1 price levels

Days at Price
7 days 0 2 4 5 7 £520 Days at Price

Price Analysis

Most common price: £520 (7 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 7 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
11 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India
98% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in India

£515.00 07 Feb 2026
The 2023-2028 Outlook for Diabetes Drugs in the United States
98% match

The 2023-2028 Outlook for Diabetes Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Diabetes Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Diabetes Care Products in the United States
97% match

The 2023-2028 Outlook for Diabetes Care Products in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Pen Insulin Syringes in the United States
97% match

The 2023-2028 Outlook for Pen Insulin Syringes in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Insulin Delivery Systems in the United States
97% match

The 2023-2028 Outlook for Insulin Delivery Systems in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Insulin Pen Needles in the United States
97% match

The 2023-2028 Outlook for Insulin Pen Needles in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Insulin Delivery Devices in the United States
97% match

The 2023-2028 Outlook for Insulin Delivery Devices in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Unfractionated Heparin in the United States
97% match

The 2023-2028 Outlook for Unfractionated Heparin in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Diabetic Ulcers in the United States
97% match

The 2023-2028 Outlook for Diabetic Ulcers in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Diabetes Diagnostic Test Strips in the United States
97% match

The 2023-2028 Outlook for Diabetes Diagnostic Test Strips in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Diabetic Neuropathy in the United States
97% match

The 2023-2028 Outlook for Diabetic Neuropathy in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Injectable Diabetes Drugs
97% match

The 2023-2028 World Outlook for Injectable Diabetes Drugs

£795.00 14 Jan 2026
The 2023-2028 Outlook for Insulin Pumps in the United States
97% match

The 2023-2028 Outlook for Insulin Pumps in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Standard Insulin Pen Needles in the United States
97% match

The 2023-2028 Outlook for Standard Insulin Pen Needles in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Insulin Infusion Pumps in the United States
96% match

The 2023-2028 Outlook for Insulin Infusion Pumps in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Diabetic Socks in the United States
96% match

The 2023-2028 Outlook for Diabetic Socks in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
96% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

£520.00 07 Feb 2026
The 2023-2028 World Outlook for Unfractionated Heparin
96% match

The 2023-2028 World Outlook for Unfractionated Heparin

£795.00 13 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026